Holdings of Invesco Nasdaq Biotechnology ETF
Invesco Exchange-Traded Fund Trust II · Original filing · Compare with another fund · Report an error
- Net assets
- 67.4M $ including 67.3M $ in equities, 99.9 %
- Positions
- 254 in 18 countries
- Top ten
- 40.7 % of net assets
- Filed on
- May 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 201 | Upstream Bio Inc | 2,840 | 23.7K $ | 0.04 % |
| 202 | Pacific Biosciences of California Inc | 15,934 | 23.7K $ | 0.04 % |
| 203 | First Tracks Biotherapeutics Inc | 1,472 | 23.5K $ | 0.03 % |
| 204 | Lakefront Biotherapeutics NV | 794 | 22.5K $ | 0.03 % |
| 205 | C4 Therapeutics Inc | 5,140 | 22.5K $ | 0.03 % |
| 206 | Evolus Inc | 3,422 | 22.4K $ | 0.03 % |
| 207 | Contineum Therapeutics Inc | 1,608 | 21.7K $ | 0.03 % |
| 208 | OmniAb Inc | 7,582 | 20.5K $ | 0.03 % |
| 209 | Altimmune Inc | 6,611 | 20.2K $ | 0.03 % |
| 210 | Vanda Pharmaceuticals Inc | 3,112 | 20.1K $ | 0.03 % |
| 211 | Enanta Pharmaceuticals Inc | 1,525 | 20.1K $ | 0.03 % |
| 212 | Larimar Therapeutics Inc | 5,736 | 20K $ | 0.03 % |
| 213 | Lexeo Therapeutics Inc | 3,850 | 19.8K $ | 0.03 % |
| 214 | Autolus Therapeutics PLC | 10,575 | 19.8K $ | 0.03 % |
| 215 | Immuneering Corp | 3,407 | 19.7K $ | 0.03 % |
| 216 | Lyell Immunopharma Inc | 1,119 | 19.4K $ | 0.03 % |
| 217 | Atea Pharmaceuticals Inc | 4,127 | 19.3K $ | 0.03 % |
| 218 | Puma Biotechnology Inc | 2,680 | 19.2K $ | 0.03 % |
| 219 | CABALETTA BIO INC | 5,083 | 19.2K $ | 0.03 % |
| 220 | REGENXBIO Inc | 2,665 | 18.7K $ | 0.03 % |
| 221 | Keros Therapeutics Inc | 1,610 | 18.1K $ | 0.03 % |
| 222 | Editas Medicine Inc | 5,143 | 17.8K $ | 0.03 % |
| 223 | SIGA Technologies Inc | 3,769 | 17.6K $ | 0.03 % |
| 224 | Rocket Pharmaceuticals Inc | 5,735 | 17.6K $ | 0.03 % |
| 225 | SILENCE THERAPEUTICS PLC | 2,476 | 17.1K $ | 0.03 % |
| 226 | Invivyd Inc | 14,607 | 16.7K $ | 0.02 % |
| 227 | Neumora Therapeutics Inc | 8,812 | 16.3K $ | 0.02 % |
| 228 | Alpha Teknova Inc | 2,824 | 15.2K $ | 0.02 % |
| 229 | Anavex Life Sciences Corp | 4,878 | 14.8K $ | 0.02 % |
| 230 | Entrada Therapeutics Inc | 2,017 | 14.3K $ | 0.02 % |
| 231 | AC Immune SA | 5,312 | 14.1K $ | 0.02 % |
| 232 | Humacyte Inc | 10,180 | 13.2K $ | 0.02 % |
| 233 | Codexis Inc | 4,766 | 13.2K $ | 0.02 % |
| 234 | Foghorn Therapeutics Inc | 3,081 | 13.2K $ | 0.02 % |
| 235 | LENZ Therapeutics Inc | 1,658 | 12.9K $ | 0.02 % |
| 236 | COHERUS ONCOLOGY INC | 7,880 | 12.5K $ | 0.02 % |
| 237 | QUANTUM-SI INC | 10,304 | 12.3K $ | 0.02 % |
| 238 | Voyager Therapeutics Inc | 3,102 | 12K $ | 0.02 % |
| 239 | Sagimet Biosciences Inc | 1,641 | 12K $ | 0.02 % |
| 240 | Arcturus Therapeutics Holdings Inc | 1,489 | 11.8K $ | 0.02 % |
| 241 | Orchestra BioMed Holdings Inc | 2,983 | 11.7K $ | 0.02 % |
| 242 | Caribou Biosciences Inc | 4,925 | 11.6K $ | 0.02 % |
| 243 | BICYCLE THERAPEUTICS PLC | 2,439 | 11.4K $ | 0.02 % |
| 244 | NovaBridge Biosciences | 5,925 | 10.9K $ | 0.02 % |
| 245 | TENAYA THERAPEUTICS INC | 11,421 | 9.9K $ | 0.01 % |
| 246 | Lifecore Biomedical Inc | 1,969 | 9.9K $ | 0.01 % |
| 247 | Jyong Biotech Ltd. | 3,924 | 8.6K $ | 0.01 % |
| 248 | Black Diamond Therapeutics Inc | 3,013 | 6.7K $ | 0.01 % |
| 249 | Pyxis Oncology Inc | 3,278 | 5.9K $ | 0.01 % |
| 250 | PepGen Inc | 3,627 | 5.4K $ | 0.01 % |
| 251 | RANI THERAPEUTICS HOLDINGS INC | 5,139 | 4.9K $ | 0.01 % |
| 252 | Aardvark Therapeutics Inc | 1,150 | 4.7K $ | 0.01 % |
| 253 | Gossamer Bio Inc | 12,208 | 2.8K $ | 0.00 % |
| 254 | CARTESIAN THERAPEUTICS INC | 2,633 | 359.2 $ | 0.00 % |
Sector breakdown
- Health care 46.5 %
- Unattributed 53.5 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 87.7 %
- Netherlands 2.5 %
- Ireland 1.9 %
- Bermuda 1.7 %
- France 1.5 %
- Denmark 1.2 %
- Germany 0.9 %
- Canada 0.7 %
- United Kingdom 0.5 %
- Switzerland 0.4 %
- Cayman Islands 0.3 %
- Jersey 0.2 %
- Other countries 0.5 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 217 | 59M $ | 87.65 % |
| 2 | Netherlands | 4 | 1.7M $ | 2.49 % |
| 3 | Ireland | 4 | 1.3M $ | 1.88 % |
| 4 | Bermuda | 1 | 1.2M $ | 1.71 % |
| 5 | France | 2 | 1M $ | 1.50 % |
| 6 | Denmark | 2 | 830.2K $ | 1.23 % |
| 7 | Germany | 1 | 586.4K $ | 0.87 % |
| 8 | Canada | 3 | 453.4K $ | 0.67 % |
| 9 | United Kingdom | 5 | 368.8K $ | 0.55 % |
| 10 | Switzerland | 2 | 302.7K $ | 0.45 % |
| 11 | Cayman Islands | 5 | 220.4K $ | 0.33 % |
| 12 | Jersey | 1 | 103.5K $ | 0.15 % |
Cite this page
Titelia. "Holdings of Invesco Nasdaq Biotechnology ETF". https://titelia.com/en/funds/S000072469